Literature DB >> 21411731

Macrophage migration inhibitory factor and CD74 regulate macrophage chemotactic responses via MAPK and Rho GTPase.

Huapeng Fan1, Pam Hall, Leilani L Santos, Julia L Gregory, Gunter Fingerle-Rowson, Richard Bucala, Eric F Morand, Michael J Hickey.   

Abstract

Macrophage migration inhibitory factor (MIF) promotes leukocyte recruitment to sites of inflammation. However, whether this stems from a direct effect on leukocyte migration is unknown. Furthermore, the role of the MIF-binding protein CD74 in this response has not been investigated. Therefore, the aim of this study was to examine the contributions of MIF and CD74 to chemokine-induced macrophage recruitment. Intravital microscopy studies demonstrated that CCL2-induced leukocyte adhesion and transmigration were reduced in MIF(-/-) and CD74(-/-) mice. MIF(-/-) and CD74(-/-) macrophages also exhibited reduced chemotaxis in vitro, although CD74(-/-) macrophages showed increased chemokinesis. Reduced CCL2-induced migration was associated with attenuated MAPK phosphorylation, RhoA GTPase activity, and actin polymerization in MIF(-/-) and CD74(-/-) macrophages. Furthermore, in MIF(-/-) macrophages, MAPK phosphatase-1 was expressed at elevated levels, providing a potential mechanism for the reduction in MAPK phosphorylation in MIF-deficient cells. No increase in MAPK phosphatase-1 expression was observed in CD74(-/-) macrophages. In in vivo experiments assessing the link between MIF and CD74, combined administration of MIF and CCL2 increased leukocyte adhesion in both MIF(-/-) and CD74(-/-) mice, showing that CD74 was not required for this MIF-induced response. Additionally, although leukocyte recruitment induced by administration of MIF alone was reduced in CD74(-/-) mice, consistent with a role for CD74 in leukocyte recruitment induced by MIF, MIF-treated CD74(-/-) mice displayed residual leukocyte recruitment. These data demonstrate that MIF and CD74 play previously unappreciated roles in CCL2-induced macrophage adhesion and migration, and they indicate that MIF and CD74 mediate this effect via both common and independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21411731      PMCID: PMC3388798          DOI: 10.4049/jimmunol.1003713

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  72 in total

1.  TAp63 regulates VLA-4 expression and chronic lymphocytic leukemia cell migration to the bone marrow in a CD74-dependent manner.

Authors:  Inbal Binsky; Frida Lantner; Valentin Grabovsky; Nurit Harpaz; Lev Shvidel; Alain Berrebi; David M Goldenberg; Lin Leng; Richard Bucala; Ronen Alon; Michal Haran; Idit Shachar
Journal:  J Immunol       Date:  2010-03-31       Impact factor: 5.422

2.  Macrophage migration inhibitory factor increases leukocyte-endothelial interactions in human endothelial cells via promotion of expression of adhesion molecules.

Authors:  Qiang Cheng; Sonja J McKeown; Leilani Santos; Fernando S Santiago; Levon M Khachigian; Eric F Morand; Michael J Hickey
Journal:  J Immunol       Date:  2010-06-16       Impact factor: 5.422

3.  Activation of CD74 inhibits migration of human mesenchymal stem cells.

Authors:  Bonnie L Barrilleaux; Benjamin W Fischer-Valuck; Jennifer K Gilliam; Donald G Phinney; Kim C O'Connor
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-03-03       Impact factor: 2.416

4.  Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74.

Authors:  Hongqi Lue; Manfred Dewor; Lin Leng; Richard Bucala; Jürgen Bernhagen
Journal:  Cell Signal       Date:  2010-08-31       Impact factor: 4.315

5.  Identification of NURR1 as a mediator of MIF signaling during chronic arthritis: effects on glucocorticoid-induced MKP1.

Authors:  Jennifer A Ralph; Afsar U Ahmed; Leilani L Santos; Andrew R Clark; Jason McMorrow; Evelyn P Murphy; Eric F Morand
Journal:  Am J Pathol       Date:  2010-09-09       Impact factor: 4.307

6.  In vivo blockade of macrophage migration inhibitory factor ameliorates acute experimental autoimmune encephalomyelitis by impairing the homing of encephalitogenic T cells to the central nervous system.

Authors:  Claudia M Denkinger; Michael Denkinger; Jens J Kort; Christine Metz; Thomas G Forsthuber
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

7.  Independent roles of macrophage migration inhibitory factor and endogenous, but not exogenous glucocorticoids in regulating leukocyte trafficking.

Authors:  Julia L Gregory; Pam Hall; Michelle Leech; Eric F Morand; Michael J Hickey
Journal:  Microcirculation       Date:  2009-11       Impact factor: 2.628

8.  Mechanistic basis of Rho GTPase-induced extracellular matrix synthesis in trabecular meshwork cells.

Authors:  Padmanabhan P Pattabiraman; Ponugoti Vasantha Rao
Journal:  Am J Physiol Cell Physiol       Date:  2009-11-25       Impact factor: 4.249

Review 9.  Dual-specificity phosphatases: critical regulators with diverse cellular targets.

Authors:  Kate I Patterson; Tilman Brummer; Philippa M O'Brien; Roger J Daly
Journal:  Biochem J       Date:  2009-03-15       Impact factor: 3.857

10.  MIF signal transduction initiated by binding to CD74.

Authors:  Lin Leng; Christine N Metz; Yan Fang; Jing Xu; Seamas Donnelly; John Baugh; Thomas Delohery; Yibang Chen; Robert A Mitchell; Richard Bucala
Journal:  J Exp Med       Date:  2003-06-02       Impact factor: 14.307

View more
  46 in total

1.  Novel anti-inflammatory activity of epoxyazadiradione against macrophage migration inhibitory factor: inhibition of tautomerase and proinflammatory activities of macrophage migration inhibitory factor.

Authors:  Athar Alam; Saikat Haldar; Hirekodathakallu V Thulasiram; Rahul Kumar; Manish Goyal; Mohd Shameel Iqbal; Chinmay Pal; Sumanta Dey; Samik Bindu; Souvik Sarkar; Uttam Pal; Nakul C Maiti; Uday Bandyopadhyay
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

2.  The human chemokine receptor CCRL2 suppresses chemotaxis and invasion by blocking CCL2-induced phosphorylation of p38 MAPK in human breast cancer cells.

Authors:  Lei-Ping Wang; Jun Cao; Jian Zhang; Bi-Yun Wang; Xi-Chun Hu; Zhi-Min Shao; Zhong-Hua Wang; Zhou-Luo Ou
Journal:  Med Oncol       Date:  2015-10-20       Impact factor: 3.064

3.  Macrophage migration inhibitory factor is essential for osteoclastogenic mechanisms in vitro and in vivo mouse model of arthritis.

Authors:  Ran Gu; Leilani L Santos; Devi Ngo; HuaPeng Fan; Preetinder P Singh; Gunter Fingerle-Rowson; Richard Bucala; Jiake Xu; Julian M W Quinn; Eric F Morand
Journal:  Cytokine       Date:  2015-01-31       Impact factor: 3.861

4.  A novel HLA-DRα1-MOG-35-55 construct treats experimental stroke.

Authors:  Gil Benedek; Wenbin Zhu; Nicole Libal; Amanda Casper; Xiaolin Yu; Roberto Meza-Romero; Arthur A Vandenbark; Nabil J Alkayed; Halina Offner
Journal:  Metab Brain Dis       Date:  2014-03       Impact factor: 3.584

Review 5.  Beta cell function: the role of macrophage migration inhibitory factor.

Authors:  Ivana Stojanovic; Tamara Saksida; Stanislava Stosic-Grujicic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

6.  Differential roles of cardiac and leukocyte derived macrophage migration inhibitory factor in inflammatory responses and cardiac remodelling post myocardial infarction.

Authors:  David A White; Yidan Su; Peter Kanellakis; Helen Kiriazis; Eric F Morand; Richard Bucala; Anthony M Dart; Xiao-Ming Gao; Xiao-Jun Du
Journal:  J Mol Cell Cardiol       Date:  2014-02-05       Impact factor: 5.000

7.  Macrophage migration inhibitory factor inhibits the antiinflammatory effects of glucocorticoids via glucocorticoid-induced leucine zipper.

Authors:  Huapeng Fan; Wenping Kao; Yuan H Yang; Ran Gu; James Harris; Günter Fingerle-Rowson; Richard Bucala; Devi Ngo; Elaine Beaulieu; Eric F Morand
Journal:  Arthritis Rheumatol       Date:  2014-08       Impact factor: 10.995

8.  Macrophage Migration Inhibitory Factor (MIF) Supports Homing of Osteoclast Precursors to Peripheral Osteolytic Lesions.

Authors:  Alexandru Movila; Takenobu Ishii; Abdullah Albassam; Wichaya Wisitrasameewong; Mohammed Howait; Tsuguno Yamaguchi; Montserrat Ruiz-Torruella; Laila Bahammam; Kazuaki Nishimura; Thomas Van Dyke; Toshihisa Kawai
Journal:  J Bone Miner Res       Date:  2016-06-02       Impact factor: 6.741

9.  Integrated in silico and 3D in vitro model of macrophage migration in response to physical and chemical factors in the tumor microenvironment.

Authors:  Sharon Wei Ling Lee; R J Seager; Felix Litvak; Fabian Spill; Je Lin Sieow; Penny Hweixian Leong; Dillip Kumar; Alrina Shin Min Tan; Siew Cheng Wong; Giulia Adriani; Muhammad Hamid Zaman; And Roger D Kamm
Journal:  Integr Biol (Camb)       Date:  2020-04-20       Impact factor: 2.192

10.  A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2.

Authors:  Shouhui Yang; Peijun He; Jian Wang; Aaron Schetter; Wei Tang; Naotake Funamizu; Katsuhiko Yanaga; Tadashi Uwagawa; Abhay R Satoskar; Jochen Gaedcke; Markus Bernhardt; B Michael Ghadimi; Matthias M Gaida; Frank Bergmann; Jens Werner; Thomas Ried; Nader Hanna; H Richard Alexander; S Perwez Hussain
Journal:  Cancer Res       Date:  2016-04-20       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.